Trainer John 4
4 · NexImmune, Inc. · Filed Apr 7, 2022
Insider Transaction Report
Form 4
NexImmune, Inc.NEXI
Trainer John
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-04-05+78,100→ 78,100 totalExercise: $4.22Exp: 2032-04-04→ Common Stock (78,100 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on April 5, 2023, with the remainder vesting in 36 equal monthly installments thereafter, subject to Mr. Trainer's continued service to the corporation on each vesting date.